Gilead Receives Complete Response Letter from U.S. Food and Drug Administration for Aztreonam Lysine for Inhalation, an Investigational Treatment for Cystic Fibrosis FOSTER CITY, Calif.--(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results